Abstract
The synthetic peptide derived from a spider toxin, Lycosa erithrognatha, LyeTxI-b, has known antitumoral and antiangiogenic activity. So, in this study we evaluated their effect on colorectal cancer (CRC), using the chicken chorioallantoic membrane (CAM) model for tumor development. On the 11th day of embryo development, the eggs were opened and the cell culture of RKO-AS-45-1 was instilled on the CAM surface and the eggs were reincubated for more 48 h. Sequentially, the LyeTxI-b was applied over the CAM. Cisplatin and phosphate-buffered saline (PBS) pH 7.4 were used as positive and negative controls, respectively (n = 6). On the 14th day of embryo development, the CAM was photographed and samples were analyzed by histology and immunohistochemistry. Lastly, the vessels around the tumor were quantified and CAM network topography analyzed. Tumor area in CAM that received LyeTxI-b showed a reduction similar to Cisplatin-treated, proven by histological analysis. Immunohistochemistry analysis showed the expression of hCDC47 in the CAM with colorectal tumor was lower after treatment with LyeTxI-b or Cisplatin. Also, LyeTxI-b or cisplatin treated CAM showed a significant reduction in area of vascularization in comparison to the vehicle-treated group. Using the CAM model it was possible to evaluate the efficacy of LyeTxI-b as a potent antitumor agent in CRC, quickly and effectively and in agreement to 3r's principle: to replace, reduce or refine the use of animals in experimentation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- AMPs:
-
Antimicrobial peptides
- ATCC:
-
American type culture collection
- CAM:
-
Chicken chorioallantoic membrane
- CRC:
-
Colorectal cancer
- PBS:
-
Phosphate buffer solution
- TA:
-
Tumor area
- VEGF:
-
Vascular endothelial growth factors
References
Abdel-Salam MAL, Carvalho-Tavares J, Gomes KS et al (2019) The synthetic peptide LyeTxI-b derived from Lycosa erythrognatha spider venom is cytotoxic to U-87 MG glioblastoma cells. Amino Acids. https://doi.org/10.1007/s00726-018-2678-4
Al-Benna S, Shai Y, Jacobsen F, Steinstraesser L (2011) Oncolytic activities of host defense peptides. Int J Mol Sci 12(11):8027–8051
Alves AP, Mesquita ON, Gómez-Gardeñes J, Agero U (2018) Graph analysis of cell clusters forming vascular networks. R Soc Open Sci 5:171592. https://doi.org/10.1098/rsos.171592
Anitha A, Maya S, Sivaram AJ et al (2016) Combinatorial nanomedicines for colon cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. https://doi.org/10.1002/wnan.1353
Avelar Júnior JT, Marques E, Castro Junior CJ et al (2020) Synergistic effect between the peptide LYETX1-B and cisplatin to kill triple negative breast cancer cells, MDA-MB-231. Toxicon 177:S54. https://doi.org/10.1016/j.toxicon.2019.12.119
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298–307
Cruz Olivo EA, Santos D, de Lima ME et al (2017) Antibacterial effect of synthetic peptide LyeTxI and LyeTxI/β-cyclodextrin association compound against planktonic and multispecies biofilms of periodontal pathogens. J Periodontol. https://doi.org/10.1902/jop.2016.160438
Da Silva FR, De Pavia MRB, Dourado LFN et al (2018) Intravitreal injection of the synthetic peptide LyeTx i b, derived from a spider toxin, into the rabbit eye is safe and prevents neovascularization in a chorio-allantoic membrane model 11 medical and health sciences 1113 ophthalmology and optometry Maria. J Venom Anim Toxins Incl Trop Dis. https://doi.org/10.1186/s40409-018-0168-5
Da Silva CN, Da Silva FR, Dourado LFN et al (2019a) A new topical eye drop containing lyetxi-b, a synthetic peptide designed from a Lycosa erithrognata venom toxin, was effective to treat resistant bacterial keratitis. Toxins (basel). https://doi.org/10.3390/toxins11040203
da Silva CN, Nunes KP, De Marco Almeida F et al (2019b) PnPP-19 peptide restores erectile function in hypertensive and diabetic animals through intravenous and topical administration. J Sex Med. https://doi.org/10.1016/j.jsxm.2019.01.004
da Silva CN, Dourado LFN, de Lima ME, da Silva C-J (2020) PnPP-19 peptide as a novel drug candidate for topical glaucoma therapy through nitric oxide release. Transl vis Sci Technol 9:33. https://doi.org/10.1167/tvst.9.8.33
DeBord LC, Pathak RR, Villaneuva M et al (2018) The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research. Am J Cancer Res 8:1642–1660
Dekker E, Tanis PJ, Vleugels JLA et al (2019) Colorectal cancer. Lancet. https://doi.org/10.1016/S0140-6736(19)32319-0
Deryugina EI, Quigley JP (2008) Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem Cell Biol 130(6):1119–1130
Deslouches B, Di Peter Y (2017) Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget. https://doi.org/10.18632/oncotarget.16743
Domalaon R, Findlay B, Ogunsina M et al (2016) Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells. Peptides. https://doi.org/10.1016/j.peptides.2016.07.007
Durupt F, Koppers-Lalic D, Balme B et al (2012) The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses. Cancer Gene Ther. https://doi.org/10.1038/cgt.2011.68
Eberhardt, NasrullahHaeussler (2019) Inhibition of caspase-2 translation by the mRNA binding protein HuR: a novel path of therapy resistance in colon carcinoma cells? Cells. https://doi.org/10.3390/cells8080797
Felício MR, Silva ON, Gonçalves S et al (2017) Peptides with dual antimicrobial and anticancer activities. Front Chem. https://doi.org/10.3389/fchem.2017.00005
Fuscaldi LL, dos Santos DM, Pinheiro NGS et al (2016) Synthesis and antimicrobial evaluation of two peptide LyeTx I derivatives modified with the chelating agent HYNIC for radiolabeling with technetium-99m. J Venom Anim Toxins Incl Trop Dis. https://doi.org/10.1186/s40409-016-0070-y
Garbin L, Cassali G, Falcao H et al (2019) Histological and immunohistochemical evaluation of two cell therapy protocols in equine suspensory ligament repair. Arq Bras Med Vet e Zootec. https://doi.org/10.1590/1678-4162-10683
Ghaffari-Tabrizi-Wizsy N, Passegger CA, Nebel L et al (2019) The avian chorioallantoic membrane as an alternative tool to study medullary thyroid cancer. Endocr Connect 8:462–467. https://doi.org/10.1530/ec-18-0431
Ghiulai R, Avram S, Stoian D et al (2020) Lemon balm extracts prevent breast cancer progression in vitro and in ovo on chorioallantoic membrane assay. Evid-Based Complement Altern Med. https://doi.org/10.1155/2020/6489159
Giatromanolaki A, Sivridis E, Koukourakis MI (2006) Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol Cancer Clin Trials. https://doi.org/10.1097/01.coc.0000221317.56731.4e
Gillen CD, Andrews HA, Prior P, Allan RN (1994) Crohn’s disease and colorectal cancer. Gut. https://doi.org/10.1136/gut.35.5.651
Gomes A, Teixeira C, Ferraz R et al (2017) Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules. https://doi.org/10.3390/molecules22101743
Hagedorn M, Javerzat S, Gilges D et al (2005) Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.0408622102
Hiraiwa A, Fujita M, Nagasaka T et al (1997) Immunolocalization of the hCDC47 protein in normal and neoplastic human tissues and its relation to growth. Int J Cancer. https://doi.org/10.1002/(SICI)1097-0215(19970422)74:2%3c180::AID-IJC7%3e3.0.CO;2-V
Honeycutt KA, Chen Z, Koster MI et al (2006) Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene 25:4027–4032. https://doi.org/10.1038/sj.onc.1209435
Hou P, Shi P, Jiang T et al (2020) DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer. Br J Cancer. https://doi.org/10.1038/s41416-019-0695-z
Kang HK, Kim C, Seo CH, Park Y (2017) The therapeutic applications of antimicrobial peptides (AMPs): a patent review. J Microbiol. https://doi.org/10.1007/s12275-017-6452-1
Kirk RGW (2018) Recovering the principles of humane experimental technique: the 3Rs and the human essence of animal research. Sci Technol Hum Values. https://doi.org/10.1177/0162243917726579
Lee EY, Lee MW, Wong GCL (2019) Modulation of toll-like receptor signaling by antimicrobial peptides. Seminars in cell & developmental biology, vol 88. Academic Press, Cambridge, pp 173–184
Leene W, Duyzings MJM, van Steeg C (1973) Lymphoid stem cell identification in the developing thymus and bursa of fabricius of the chick. Zeitschrift Für Zellforsch Und Mikroskopische Anat. https://doi.org/10.1007/BF00307368
Lokman NA, Elder ASF, Ricciardelli C, Oehler MK (2012) Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci. https://doi.org/10.3390/ijms13089959
Mader JS, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs. https://doi.org/10.1517/13543784.15.8.933
Marley AR, Nan H (2016) Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet 7(3):105–114
Melo-Braga MN, Almeida FDM, dos Santos DM et al (2020) Antimicrobial peptides from lycosidae (Sundevall, 1833) spiders. Curr Protein Pept Sci. https://doi.org/10.2174/1389203721666200116091911
Mody K, Baldeo C, Bekaii-Saab T (2018) Antiangiogenic therapy in colorectal cancer. Cancer J 24:165–170. https://doi.org/10.1097/PPO.0000000000000328
National Institute of Health - National Cancer Institute (2021) Cancer statistics, cancer stat facts: Colorectal cancer. https://seer.cancer.gov/statfacts/html/colorect.html
Nishihara K, Shomori K, Fujioka S et al (2008) Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol. https://doi.org/10.3892/ijo_00000003
Nowak-Sliwinska P, Van Beijnum JR, Van Berkel M et al (2010) Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane. Angiogenesis. https://doi.org/10.1007/s10456-010-9185-x
Oliveira CFB, Alves DP, Emerich BL et al (2019) Antinociceptive effect of PnTx4(5–5), a peptide from Phoneutria nigriventer spider venom, in rat models and the involvement of glutamatergic system. J Venom Anim Toxins Incl Trop Dis. https://doi.org/10.1590/1678-9199-jvatitd-2019-0022
Pérez-Pitarch A, Guglieri-López B, Nacher A et al (2017) Impact of undernutrition on the pharmacokinetics and pharmacodynamics of anticancer drugs: a literature review. Nutr Cancer. https://doi.org/10.1080/01635581.2017.1299878
Reis PVM, Boff D, Verly RM et al (2018) LyeTxI-b, a synthetic peptide derived from Lycosa erythrognatha spider venom, shows potent antibiotic activity in vitro and in vivo. Front Microbiol. https://doi.org/10.3389/fmicb.2018.00667
Ribatti D (2008) Chapter 5 chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol 270:181–224
Ribatti D (2014) The chick embryo chorioallantoic membrane as a model for tumor biology. Exp Cell Res. https://doi.org/10.1007/978-94-017-9716-0_12
Ribatti D (2016) The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model. Mech Dev 141:70–77
Rojiani MV, Siemann DW, Rojiani AM (2010) Cell proliferation index determination by immunohistochemical detection of hCDC47 protein. Appl Immunohistochem Mol Morphol. https://doi.org/10.1097/PAI.0b013e3181c6c949
Rosen LS, Jacobs IA, Burkes RL (2017) Bevacizumab in colorectal cancer: current role in treatment and the potential of biosimilars. Target Oncol 12(5):599–610
Santos DM, Verly RM, Piló-Veloso D et al (2010) LyeTx I, a potent antimicrobial peptide from the venom of the spider Lycosa erythrognatha. Amino Acids. https://doi.org/10.1007/s00726-009-0385-x
Schweizer F (2009) Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 1–3(2009):190–194
Shi P, Hong J, Huang Y et al (2014) Automated computational framework of blood vessel quantification in chick chorioallantoic membrane angiogenesis. J Biomed Opt. https://doi.org/10.1117/1.jbo.19.10.106005
Taizi M, Deutsch VR, Leitner A et al (2006) A novel and rapid in vivo system for testing therapeutics on human leukemias. Exp Hematol. https://doi.org/10.1016/j.exphem.2006.07.005
Tampellini M, Sonetto C, Scagliotti GV (2016) Novel anti-angiogenic therapeutic strategies in colorectal cancer. Expert Opin Investig Drugs. https://doi.org/10.1517/13543784.2016.1161754
Toledo CR, Pereira VV, Dourado LFN et al (2019) Corosolic acid: antiangiogenic activity and safety of intravitreal injection in rats eyes. Doc Ophthalmol. https://doi.org/10.1007/s10633-019-09682-x
Valiulytė I, Curkūnavičiūtė R, Ribokaitė L et al (2019) The anti-tumorigenic activity of sema3C in the chick embryo chorioallantoic membrane model. Int J Mol Sci. https://doi.org/10.3390/ijms20225672
Van Der Jeught K, Xu HC, Li YJ et al (2018) Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 2434:3834
Vu BT, Shahin SA, Croissant J et al (2018) Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer. Sci Rep 8:1–10. https://doi.org/10.1038/s41598-018-25573-8
Wang R, Ma Y, Zhan S et al (2020) B7–H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Cell Death Dis. https://doi.org/10.1038/s41419-020-2252-3
Wu D, Gao Y, Qi Y et al (2014) Peptide-based cancer therapy: opportunity and challenge. Cancer Lett. https://doi.org/10.1016/j.canlet.2014.05.002
Xie YH, Chen YX, Fang JY (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5(1):1–30
Zhong M, Li N, Qiu X et al (2020) TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Int J Biol Sci. https://doi.org/10.7150/ijbs.37906
Acknowledgements
FAPEMIG, CNPq and CAPES for financial support. This study is part of the National Institute of Science and Technology in Pharmaceutical Nanotechnology: a transdisciplinary approach INCT-NANOFARMA, which is supported by São Paulo Research Foundation (FAPESP, Brazil) Grant #2014/50928-2, and by ‘‘Conselho Nacional de Desenvolvimento Científico e Tecnológico’’ (CNPq, Brazil) Grant # 465687/2014-8.
Author information
Authors and Affiliations
Contributions
CNS, LFND—Data curation, formal analysis, investigation, methodology, validation, writing-original draft (Lead). These authors equally contributed to this manuscript. ASC-Jr, SLF—Conceptualization (Lead), Project administration (Lead). CNS, ASC-Jr, SLF—Funding acquisition (Lead). LMS, ABL—Methodology (Supporting), writing-original draft (Supporting). MEL, LMS, ASC-Jr, SLF—Resources, writing-review & editing (Lead).
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical Approval
Not applicable.
Consent for Publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
da Silva, C.N., Dourado, L.F.N., Silva, L.M. et al. Pathophysiological Effects of Lycosa erythrognatha Derived Peptide LyeTxI-b on RKO-AS-45-1 Colorectal Carcinoma Cell Line Using the Chicken Chorioallantoic Membrane Model. Int J Pept Res Ther 28, 36 (2022). https://doi.org/10.1007/s10989-021-10349-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s10989-021-10349-y